"Glucosamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D005944
|
| MeSH Number(s) |
D09.067.342.531
|
| Concept/Terms |
Glucosamine- Glucosamine
- 2-Amino-2-Deoxyglucose
- 2 Amino 2 Deoxyglucose
|
Below are MeSH descriptors whose meaning is more general than "Glucosamine".
Below are MeSH descriptors whose meaning is more specific than "Glucosamine".
This graph shows the total number of publications written about "Glucosamine" by people in this website by year, and whether "Glucosamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2009 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucosamine" by people in Profiles.
-
The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination. Osteoarthritis Cartilage. 2010 Mar; 18(3):297-302.
-
The effects of oral glucosamine on joint health: is a change in research approach needed? Osteoarthritis Cartilage. 2010 Jan; 18(1):5-11.
-
Oral glucosamine modulates the response of the liver and lymphocytes of the mesenteric lymph nodes in a papain-induced model of joint damage and repair. Osteoarthritis Cartilage. 2009 Aug; 17(8):1014-21.
-
The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis. Arthritis Rheum. 2007 May; 56(5):1537-48.
-
Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J Biol Chem. 2007 May 25; 282(21):15439-50.
-
Nonarthroplasty treatment of glenohumeral cartilage lesions. Arthroscopy. 2005 Sep; 21(9):1131-42.
-
Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses. Arthritis Rheum. 2005 Jan; 52(1):181-91.
-
Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem J. 1998 Oct 01; 335 ( Pt 1):59-66.
-
The identification and characterization of two populations of aggregating proteoglycans of high buoyant density isolated from post-natal human articular cartilages of different ages. Biochem J. 1987 Dec 15; 248(3):735-40.
-
Differential regulation of multiple neuroreceptors in a somatic cell hybrid by inhibitors of glycoprotein processing. Biochem Biophys Res Commun. 1986 Feb 13; 134(3):1387-94.